检索结果-南通市图书馆

在线全文

学校读者我要写书评

暂无评论

双心门诊建设规范中国专家共识

中国全科医学 2024年第3期27卷 253-261页

作者：中华医学会心身医学分会中国康复医学会心血管病预防与康复专委会丁荣晶刘园园袁丽霞王一波李忠艳袁勇贵胡大一不详中国医学科学院北京协和医院北京市100032 天津市胸科医院 300350 河南省郑州市第七人民医院 450016 上海交通大学医学院附属第九人民医院黄浦分院上海市200011 大连医科大学附属第二医院辽宁省大连市116033 东南大学附属中大医院北京大学人民医院

临床上,心血管疾病患者广泛存在精神心理问题,两者相互影响,加重疾病状态。双心医学是一门由心脏病学和心理学交叉并综合形成的学科,强调关注心血管疾病的同时关注患者的精神心理状态。中华医学会心身医学分会双心学组的专家们经查阅文... 详细信息

临床上,心血管疾病患者广泛存在精神心理问题,两者相互影响,加重疾病状态。双心医学是一门由心脏病学和心理学交叉并综合形成的学科,强调关注心血管疾病的同时关注患者的精神心理状态。中华医学会心身医学分会双心学组的专家们经查阅文献、开展研讨,制定了《双心门诊建设规范中国专家共识》,以完善并提高我国双心医学诊治能力,推动各级医疗机构开设双心门诊,不断健全我国双心医疗服务体系。

关键词：双心医学双心疾病心脏病学心理学门诊医疗设施共识指南

chinese Guideline on the Primary prevention of cardiovascular diseases

同方期刊数据库博看期刊评论

在线全文

学校读者我要写书评

暂无评论

Cardiology Discovery 2021年第2期1卷 70-104页

作者： chinese Society of Cardiology of chinese Medical association cardiovascular disease prevention and rehabilitation committee of chinese association of rehabilitation medicine cardiovascular disease committee of chinese association of Gerontology and Geriatrics Thrombosis prevention and Treatment committee of chinese Medical Doctor association Dayi Hu Yaling Han Guang Ning Changsheng Ma 不详 Peking University People’s Hospital General Hospital of Northern Theater Command Ruijin Hospital Affiliated to Shanghai Jiaotong University School of medicine Beijing Anzhen Hospital Capital Medical University

cardiovascular disease is the leading cause of mortality in *** prevention of cardiovascular disease with a focus on lifestyle intervention and risk factor control has been shown to effectively delay or prevent the occurrence of cardiovascular *** promote a healthy lifestyle and enhance the detection,diagnosis,and treatment of cardiovascular risk factors such as hypertension,dyslipidemia,and diabetes,and to improve the overall capacity of primary prevention of cardiovascular disease,the chinese Society of Cardiology of chinese Medical association has collaborated with multiple societies to summarize and evaluate the latest evidence with reference to relevant guidelines and subsequently to develop recommendations for primary cardiovascular disease prevention in chinese *** guideline consists of 10 sections:introduction,methodology for developing the guideline,epidemiology of cardiovascular disease in China and challenges in primary prevention,general recommendations for primary prevention,assessment of cardiovascular risk,lifestyle intervention,blood pressure control,lipid management,management of type 2 diabetes,and use of *** promulgation and implementation of this guideline will play a key role in promoting the practice of primary prevention for cardiovascular disease in China.

关键词： cardiovascular disease Primary prevention Guideline

Evidence-based expert consensus on clinical management of safety of Bruton’s tyrosine kinase inhibitors(2024)

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

chinese Journal of Cancer Research 2024年第3期36卷 240-256页

作者： Zaiwei Song Dan Jiang Lingling Yu Yixuan Chen Daobin Zhou Yue Li Depei Wu Lingli Zhang Liyan Miao Jun Ma Jun Zhu Hongmei Jing Rongsheng Zhao the Steering committee,the Consensus Panel and the Evidence Synthesis Group Evidence-based Pharmacy Professional committee of chinese Pharmaceutical association(CPA) Hospital Pharmacy Professional committee of chinese Pharmaceutical association(CPA) Division of Therapeutic Drug Monitoring of chinese Pharmacological Society(CPS) Expert committee on Lymphoma of chinese Society of Clinical Oncology(CSCO) Expert committee on Leukemia of chinese Society of Clinical Oncology(CSCO) Society of Integrative Cardio-Oncology of China Anti-Cancer association(CACA) chinese Society of Hematology of chinese Medical association(CMA) Hospital Pharmacy Professional committee of Cross-Straits medicine Exchange association(SMEA) Department of Pharmacy Peking University Third HospitalBeijing 100191China Institute for Drug Evaluation Peking University Health Science CenterBeijing 100191China Therapeutic Drug Monitoring and Clinical Toxicology Center Peking UniversityBeijing 100191China Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical SciencesPeking UniversityBeijing 100191China Department of Hematology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100005China Department of Cardiology the First Affiliated HospitalHarbin Medical UniversityHarbin 150001China Department of Hematology the First Affiliated Hospital of Soochow UniversitySuzhou 215006China Department of Pharmacy Evidence-based Pharmacy CenterWest China Second HospitalSichuan UniversityChengdu 610041China Department of Pharmacy the First Affiliated Hospital of Soochow UniversitySuzhou 215006China Department of Hematology and Oncology Harbin Institute of Hematology and OncologyHarbin 150010China Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) Department of LymphomaPeking University Cancer Hospital&InstituteBeijing 100142China Department of Hematology Peking University Third HospitalBeijing 100191China 不详

Bruton’s tyrosine kinase inhibitors(BTKis)have revolutionized the treatment of B-cell ***,safety issues related to the use of BTKis may hinder treatment continuity and further affect clinical efficacy.A comprehensive and systematic expert consensus from a pharmacological perspective is lacking for safety issues associated with BTKi treatment.A multidisciplinary consensus working group was established,comprising 35 members from the fields of hematology,cardiovascular disease,cardio-oncology,clinical pharmacy,and evidencebased *** evidence-based expert consensus was formulated using an evidence-based approach and the Delphi *** Joanna Briggs Institute Critical Appraisal(JBI)tool and Grading of Recommendations Assessment,Development,and Evaluation(GRADE)approach were used to rate the quality of evidence and grade the strength of recommendations,*** consensus provides practical recommendations for BTKis medication based on nine aspects within three domains,including the management of common adverse drug events such as bleeding,cardiovascular events,and hematological toxicity,as well as the management of drug-drug interactions and guidance for special *** multidisciplinary expert consensus could contribute to promoting a multi-dimensional,comprehensive and standardized management of BTKis.

关键词： Consensus BTK inhibitors safety adverse drug events drug-drug interactions

在线全文

学校读者我要写书评

暂无评论

中国心血管病一级预防指南基层版

中华心血管病杂志 2023年第4期51卷 343-363页

作者：中华医学会心血管病学分会中国康复医学会心脏预防与康复专业委员会中国老年学和老年医学会心脏专业委员会中国医师协会心血管内科医师分会血栓防治专业委员会胡大一韩雅玲宁光马长生刘静孙艺红彭道泉张宇清刘靖不详首都医科大学附属北京安贞医院中日友好医院中南大学湘雅二医院中国医学科学院阜外医院北京大学人民医院

心血管病是威胁我国人民生命和健康的重大公共卫生问题。实践证明,在心血管病事件发生之前,可以通过生活方式干预和危险因素防控等一级预防措施延缓或避免临床事件的发生。2020年,由中华医学会心血管病学分会牵头,联合相关学会共同制定... 详细信息

心血管病是威胁我国人民生命和健康的重大公共卫生问题。实践证明,在心血管病事件发生之前,可以通过生活方式干预和危险因素防控等一级预防措施延缓或避免临床事件的发生。2020年,由中华医学会心血管病学分会牵头,联合相关学会共同制定了《中国心血管病一级预防指南》。为全面推进该指南的推荐建议在基层落地,推动“以治病为中心”向“以人民健康为中心”转移,专家工作组进一步结合基层心血管病防治的特点,给出有关心血管病风险评估、生活方式干预、血压管理、血脂管理、2型糖尿病管理和阿司匹林的使用等心血管病一级预防措施的推荐建议,并以问答形式进行解释说明。

关键词：心血管疾病一级预防指南基层

Stress Echocardiography for Chronic Coronary Syndrome:Clinical Practice Guidelines(2023)

在线全文

学校读者我要写书评

暂无评论

Journal of Geriatric Cardiology 2024年第5期21卷 475-505页

作者： Peng-Fei ZHANG Jia-Wei TIAN Tian-Gang ZHU Jue-Fei WU Xiao-Ping LENG Yi WANG Meng-Meng LI Xin-Hao LI Qian-Qian WANG Xiao-Peng FENG Jia-Yan LV Li-Xue YIN Yun ZHANG Mei ZHANG chinese Society of Echocardiography,Superficial Tissue and Vascular Group of chinese Society of Ultrasound in medicine,Ultrasound Professional committee of chinese medicine Education association State Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function ResearchChinese Ministry of EducationChinese National Health Commission and Chinese Academy of Medical SciencesDepartment of CardiologyQilu Hospital of Shandong UniversityJinanChina The Second Affiliated Hospital of Harbin Medical University HaerbinChina Peking University People's Hospital BeijingChina Sichuan Province People's Hospital ChengduChina Nanfang Hospital Southern Medical UniversityGuangzhouChina Peking Union Medical College Hospital Chinese Academy of Medical SciencesBeijingChina 不详

In the context of the People's Republic of China,coronary artery disease(CAD)presents a sig-nificant clinical challenge,with over 11.3 mil-lion patients ***,the diagnos-is of CAD has predominantly relied on invasive coronary angiography.[1]However,recent advances in clinical research have revealed a notable trend:a substantial 82% of patients subjected to such invas-ive diagnostics do not necessitate interventional therapy.

关键词： coronary clinical patients

腰椎融合内固定术患者骨质疏松相关并发症预防指南(2024)

在线全文

学校读者我要写书评

暂无评论

中华骨与关节外科杂志 2024年第5期17卷 389-403页

作者：中华预防医学会脊柱疾病预防与控制专业委员会中国康复医学会骨质疏松预防与康复专业委员会李危石邹达范东伟不详北京大学第三医院

随着人口老龄化的加剧,越来越多的腰椎退行性疾病患者合并骨质疏松症。骨质疏松症患者在腰椎融合内固定术后出现内固定失败、假关节形成等并发症的风险更高,严重影响预后。目前,该患者群体骨质疏松症漏筛、漏诊现象较普遍,药物治疗率偏... 详细信息

随着人口老龄化的加剧,越来越多的腰椎退行性疾病患者合并骨质疏松症。骨质疏松症患者在腰椎融合内固定术后出现内固定失败、假关节形成等并发症的风险更高,严重影响预后。目前,该患者群体骨质疏松症漏筛、漏诊现象较普遍,药物治疗率偏低,且相关诊疗规范尚不完善。已有指南或共识对骨质疏松症本身的诊疗问题提供了重要指导,但缺乏针对腰椎融合内固定术患者群体的相关内容,不利于其骨质疏松相关手术并发症的预防。因此,中华预防医学会脊柱疾病预防与控制专业委员会联合中国康复医学会骨质疏松预防与康复专业委员会组成专家组,遵循指南制定原则和方法,遴选出10个关键临床问题,基于相关循证医学证据,采用GRADE证据质量分级方法,通过4轮专家讨论会,最终形成19条推荐意见。本指南内容主要涉及术前骨密度精准评估与骨质疏松症诊断,术中骨质疏松相关并发症预防要点,术后抗骨质疏松用药、患者管理及康复,旨在通过“术前-术中-术后”的综合管理策略,有效降低腰椎融合内固定术患者骨质疏松相关并发症的发生风险。

关键词：骨质疏松腰椎融合内固定术腰椎退行性疾病指南

在线全文

学校读者我要写书评

暂无评论

老年康复患者住院病案书写要点专家共识

康复学报 2024年第4期34卷 336-340,348页

作者：中国康复医学会老年康复专业委员会山林林王玉龙郑洁皎不详深圳大学第一附属医院深圳市第二人民医院复旦大学附属华东医院

老年康复是康复医学的重要分支,全面、准确地表述老年康复患者的疾病诊断、功能评定、康复治疗计划、康复医嘱以及记录康复过程中的功能变化至关重要。目前,我国康复医疗机构尚无统一的老年康复患者住院病案的书写规范。制定《老年康复... 详细信息

老年康复是康复医学的重要分支,全面、准确地表述老年康复患者的疾病诊断、功能评定、康复治疗计划、康复医嘱以及记录康复过程中的功能变化至关重要。目前,我国康复医疗机构尚无统一的老年康复患者住院病案的书写规范。制定《老年康复患者住院病案书写要点专家共识》有助于为从事老年康复的专业技术人员规范化书写康复临床病案提供指导和参考。本专家共识对老年康复病案规范化书写的基本原则、主要内容进行制定。康复病案主要内容包括主诉和现病史、康复专科检查、诊断[疾病诊断(主要诊断、基础疾病、并发症和合并症)、功能诊断(生理功能障碍、心理功能障碍、日常生活活动能力)]、康复治疗计划、医嘱[临时医嘱(常规检查、辅助检查和功能评定)、长期医嘱(康复医学科护理常规医嘱、药物使用医嘱和康复治疗医嘱等)]、病程记录、出院记录、住院病案首页。

关键词：老年康复住院病案功能诊断康复治疗专家共识

维普期刊数据库博看期刊

Lung Ultrasound Protocol for Diagnosis of 2019-nCoV Pneumonia and Remote Consultation( 1st Edition)

在线全文

学校读者我要写书评

暂无评论

中华超声影像学杂志 2020年第2期 93-103页

作者： Ultrasound medicine Society chinese Medical association Respiratory disease Society chinese Medical association cardiovascular Imaging Group of cardiovascular disease Society chinese Medical association Ultrasound medicine committee China medicine Education association Sichuan Ultrasound medicine Quality Control Center

Since December 2019, the emergence of a new type of coronavirus (SARA-CoV-2) pneumonia (COVID-19) in Wuhan, Hubei Province, has become a national public health emergency. The disease diagnosis is currently confirmed to be based on nucleic acid test and high-resolution CT (High Resolution CT, HRCT). Lung ultrasound (LUS) has been used in clinical practice in the differential diagnosis of lung exudative inflammation lesions, and in the evaluation of thoracic effusion, pneumothorax and the evaluation of patients with dyspnea and acute respiratory failure, as well as in the treatment monitoring to guide the treatment more efficiently. The clinical LUS application has been formed a number of domestic and foreign expert consensus. As a fast, convenient, radiation-free and easy-to-implement lung disease visualization technology at the bedside, LUS plays a role in the treatment of critically ill patients of COVID-19 . In view of the problems of LUS performance in different lung diseases, LUS has not been widely used in front-line clinic and ICU and needs to be fully mastered by clinicians in routine practice. Starting from the increasing number of severe patients with COVID-19 pneumonia, the urgent need for immediate dynamic and effective image monitoring of lung lesions in severe patients bedside and the actual clinical needs of the accurate disease changes assessment and the evaluation of treatment timely, in line with the principle of ""problem-oriented, information technology support, model innovation"", the integration of various resources, and put forward a targeted short-term can achieve a wide range of efficient applications of LUS technology of the COVID-19 pneumonia, an enhenced remote diagnosis consultation platform should be established. To promote the clinical application of LUS in the routine diagnosis and treatment of COVID-19 pneumonia in various regions, it is recommended to use the 5G remote consultation platform to achieve cross-institutional, cross-regio

关键词：

Interpretive Criteria of Grated Exercise Test Results (Draft)

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

心血管康复医学杂志 1998年第1期 6-7页

作者： LIU Jiangsheng writes(cardiovascular committee of chinese association of rehabilitation medicine)

Now the exercise test is not simply a method to determine the likelihood of CAD, but to cstimate prognosis, instruct therapy even more. It is used for assessing the functional severity of CAD and the prognosis or potential risk for future cardiac events, determining exercise prescription and effects of therapy for rehabilitative cardiology. In order to meet the needs of reference for cardiovascular rehabilitation medicine, formulate this interpretive criteria in accordance with progress recently in grated exercise test.

关键词： Grated exercise test cardiovascular rehabilitation medicine Coronary atherosclerotic heart disease (CAD)